{
    "Trade/Device Name(s)": [
        "VITEK 2 Gram Negative Trimethoprim/sulfamethoxazole",
        "VITEK 2 AST-GN SXT"
    ],
    "Submitter Information": "bioMerieux, Inc.",
    "510(k) Number": "K073406",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041982"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "January 23, 2008",
    "Summary Letter Received Date": "December 4, 2007",
    "Submission Date": "November 29, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trimethoprim/sulfamethoxazole"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of gram-negative organisms"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Quantitative MIC determination",
        "Microdilution methodology"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Card",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 Gram Negative Trimethoprim/sulfamethoxazole antimicrobial susceptibility test card for use on VITEK 2 and VITEK 2 Compact systems.",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of gram-negative organisms using VITEK 2 and VITEK 2 Compact systems to determine in vitro susceptibility to trimethoprim/sulfamethoxazole.",
    "fda_folder": "Microbiology"
}